Advertisement
Metsera, Inc.

Metsera, Inc. (MTSR) Stock Overview

Explore Metsera, Inc.โ€™s financial performance, market position, analyst ratings, and future outlook.

MTSRโ—NASDAQ
HealthcareBiotechnology
$70.50
$0.25(0.35%)
U.S. Market is Open ยท 12:31
Advertisement

Metsera, Inc. (MTSR)

Meyka AI Score

Z

Key Financials

Market Cap7.4B
P/E Ratio-23.55
EPS (TTM)$-2.99
ROE-0.80%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

MTSR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Metsera, Inc. (MTSR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -23.55 and a market capitalization of 7.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
97.65%
6-Month Change
139.96%
Year-to-Date (YTD) Change
166.04%
1-Year Change
166.04%
3-Year Change
166.04%
5-Year Change
166.04%
All-Time (Max) Change
166.04%

Contact Information

212 784 6595
3 World Trade Center, New York City, NY, 10007

Company Facts

930 Employees
IPO DateJan 31, 2025
CountryUS

Frequently Asked Questions